Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-4-19
pubmed:abstractText
Cytomegalovirus (CMV) transfusion-transmitted disease (TTD) remains a clinical concern. Universal leukoreduction has become one of the main strategies for the prevention of CMV-TTD. Through prospective clinical follow-up and testing of transfusion recipients (TRs), the risk for CMV-TTD was studied.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1537-2995
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
776-86
pubmed:meshHeading
pubmed-meshheading:19912585-Adolescent, pubmed-meshheading:19912585-Adult, pubmed-meshheading:19912585-Aged, pubmed-meshheading:19912585-Antibodies, Viral, pubmed-meshheading:19912585-Blood Donors, pubmed-meshheading:19912585-Blood Transfusion, pubmed-meshheading:19912585-Connecticut, pubmed-meshheading:19912585-Cytomegalovirus Infections, pubmed-meshheading:19912585-DNA, pubmed-meshheading:19912585-DNA Primers, pubmed-meshheading:19912585-DNA Probes, pubmed-meshheading:19912585-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:19912585-Female, pubmed-meshheading:19912585-Follow-Up Studies, pubmed-meshheading:19912585-Humans, pubmed-meshheading:19912585-Leukocyte Reduction Procedures, pubmed-meshheading:19912585-Male, pubmed-meshheading:19912585-Middle Aged, pubmed-meshheading:19912585-Prospective Studies, pubmed-meshheading:19912585-Risk Factors, pubmed-meshheading:19912585-Serotyping
pubmed:year
2010
pubmed:articleTitle
Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction.
pubmed:affiliation
Department of Laboratory Medicine, Yale University School of Medicine, 20 York Street, CB 459, New Haven, CT 06510-3202, USA. yan.wu@yale.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't